por filla | May 9, 2022 | Ana Maria Vega L.
Intravenous Administration of Bone Marrow-Derived Mesenchymal Stem Cells Induce a Switch from Classical to Atypical Symptoms in Experimental Autoimmune Encephalomyelitis (EAE). Stem Cells Int. 2015; 2015:140170. doi: 10.1155/2015/140170. AbstractPotent...
por filla | May 9, 2022 | Ana Maria Vega L.
Overexpression of Glutamate Decarboxylase In Mesenchymal Stem Cells Enhances Their Immunosuppressive Properties And Increases GABA And Nitric Oxide Levels. PLoS One. 2016 Sep 23;11(9):e0163735. doi: 10.1371/journal.pone.0163735. AbstractThe neurotransmitter GABA has...
por filla | May 9, 2022 | Ana Maria Vega L.
Toll-like receptor 3 pre-conditioning increase the therapeutic efficacy of umbilical cord mesenchymal stem cells in a DSS-induced colitis mouse model. Cytotherapy, 2016; 18: 630–641 AbstractBackground aims: Immunomodulatory properties of human umbilical cord-derived...
por filla | May 9, 2022 | Ana Maria Vega L.
Differential TLR activation of murine mesenchymal stem cells generates distinct immunomodulatory effects in EAE. Stem Cell Res Ther. 2016 Oct 10;7(1):150. AbstractBackground: Recently, it has been observed that mesenchymal stem cells (MSCs) can modulate their...
por filla | May 9, 2022 | Ana Maria Vega L.
Gilz-Activin A as a Novel Signaling Axis Orchestrating Mesenchymal Stem Cell and Th17 Cell Interplay. Theranostics. 2018; 8(3): 846–859.Published online 2018 Jan 1. doi: 10.7150/thno.21793. AbstractMesenchymal stem cells (MSC) are highly immunosuppressive cells able...
por filla | May 9, 2022 | Ana Maria Vega L.
IL17/IL17RA as a Novel Signaling Axis Driving Mesenchymal Stem Cell Therapeutic Function in Experimental Autoimmune Encephalomyelitis. Front. Immunol., 30 April 2018. https://doi.org/10.3389/fimmu.2018.00802. AbstractThe therapeutic effect of mesenchymal stem cells...